pilot study
-
Biologics
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
Company plans to begin 30-patient trial later this year April 11, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a…
Read More » -
Recon
Clinical Pilot Study Confirms the Accuracy and Effectiveness of Pixee Medical’s Knee+ Solution Using Vuzix M400 Smart Glasses for Total Knee Arthroplasty
– Vuzix receives follow-on M400 Smart Glasses order from Pixee Medical ROCHESTER, N.Y., Sept. 17, 2021 /PRNewswire/ — Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or, the…
Read More » -
Biologics
BONESUPPORT™ Announces Results Of CERAMENT™|BONE VOID FILLER Prospective Pilot Study Demonstrating Complete Bone Remodeling In Benign Bone Tumors
LUND, Sweden, Dec. 10, 2015 /PRNewswire/ — BONESUPPORT™, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument…
Read More » -
Spine
InVivo’s pilot study expands to 10 spinal cord injury patients — 5 key notes
By Laura Dyrda The FDA approved an expansion for the InVivo pilot study for the investigational Neuro-Spinal Scaffold. Here are five key…
Read More » -
Hospitals
InVivo Therapeutics Announces Expansion of Number of Patients in Pilot Study InVivo Therapeutics Holdings Corp.
InVivo Therapeutics Holdings Corp. (NVIV) today announced that the U.S. Food and Drug Administration (FDA) has approved the expansion of the…
Read More » -
Spine
InVivo Therapeutics Announces Enrollment of Fifth Patient in Pilot Spinal Cord Injury Study
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the fifth patient has been enrolled in the company’s ongoing pilot…
Read More » -
Facet Solutions Announces 2 Year Data from US Pilot Study
HOPKINTON, Mass., April 23 /PRNewswire/ — Facet Solutions, Inc. today announced that it has finished compiling two year data from its lumbar…
Read More »